Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire David Einhorn’s Greenlight Capital Re, Ltd. (GLRE) Bought Apple Inc. (AAPL), Sold Microsoft Corporation (MSFT) During Q1

Billionaire David Einhorn of Greenlight Capital Re, Ltd. (NASDAQ:GLRE) is one of the most closely followed hedge fund managers in the world. In mid May, his fund filed its 13F with the SEC, disclosing many of its long equity positions in U.S. stocks as of the end of March. Even though the information in these is a bit old, we have shown that 13Fs can be used to develop profitable investment strategies (for example, by our reckoning the most popular small cap stocks among hedge funds generate an average excess return of 18 percentage points per year). In addition, investors can always treat movements that these managers made during the previous quarter as initial ideas, going on to further research any which seem interesting on their own merits. We have gone through Einhorn’s most recent 13F compared to previous filings (see what Greenlight has owned over time) and here are three things we noticed that we was up to:

Loyal to Apple. We’ve noticed when looking at a number of billionaires’ filings that they sold Apple Inc. (NASDAQ:AAPL); this group includes David Tepper’s Appaloosa Management (find Appaloosa’s favorite stocks) and legendary investor Julian Robertson (research stocks Robertson owns). Einhorn was buying, however, and by the end of March his fund owned 2.4 million shares- a position worth over $1 billion at the time. In its most recent quarter, Apple Inc. (NASDAQ:AAPL)’s earnings dropped by 18% compared to the same period in the previous fiscal year even as revenue rose by 11% as investor fears of lower margins came true. Currently, Apple Inc. (NASDAQ:AAPL) is valued at 10 times its trailing earnings (with cash comprising a significant share of the market cap). According to our database, Apple Inc. (NASDAQ:AAPL) actually regained the title of the most popular stock among hedge funds during the first quarter of 2013 (see the rest of the top three).

David Einhorn GREENLIGHT CAPITALNot to Microsoft, though. Greenlight Capital Re, Ltd. (NASDAQ:GLRE) wasn’t as optimistic about Apple Inc. (NASDAQ:AAPL)’s longtime rival Microsoft Corporation (NASDAQ:MSFT), cutting its stake by nearly 40% to 6.1 million shares. Microsoft Corporation (NASDAQ:MSFT) trades at 11 times expected earnings for the fiscal year ending in June 2014, though if we were going to look at the company more closely we’d try to account for the fact that earnings in that year might be temporarily swelled by the release of Windows 8 and the new version of Office. We’d note that Microsoft Corporation (NASDAQ:MSFT) also has a good deal of cash on hand, though not as much as Apple Inc. (NASDAQ:AAPL) of course, and pays a dividend yield close to 3% at current prices and dividend levels. Platinum Asset Management, managed by billionaire Kerr Neilson, has been another major shareholder of Microsoft Corporation (NASDAQ:MSFT) (check out Neilson’s stock picks).

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.